These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 27629248)
1. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Werb D; Garfein R; Kerr T; Davidson P; Roux P; Jauffret-Roustide M; Auriacombe M; Small W; Strathdee SA Harm Reduct J; 2016 Sep; 13(1):25. PubMed ID: 27629248 [TBL] [Abstract][Full Text] [Related]
2. Gender differences in the provision of injection initiation assistance: a comparison of three North American settings. Meyers SA; Scheim A; Jain S; Sun X; Milloy MJ; DeBeck K; Hayashi K; Garfein RS; Werb D Harm Reduct J; 2018 Dec; 15(1):59. PubMed ID: 30514384 [TBL] [Abstract][Full Text] [Related]
3. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012. Kim NJ; Jin H; McFarland W; Raymond HF Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768 [TBL] [Abstract][Full Text] [Related]
4. History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA. Mittal ML; Vashishtha D; Sun S; Jain S; Cuevas-Mota J; Garfein R; Strathdee SA; Werb D Subst Abuse Treat Prev Policy; 2017 Oct; 12(1):42. PubMed ID: 28974239 [TBL] [Abstract][Full Text] [Related]
5. Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts. Sa M; C R; Ml M; Lr S; J TM; S J; X S; Rs G; Sa S; K D; K H; R M; Mj M; M O; A G; D W; Ai S Int J Drug Policy; 2021 Apr; 90():103056. PubMed ID: 33310638 [TBL] [Abstract][Full Text] [Related]
6. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M; BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda. Robertson AM; Garfein RS; Wagner KD; Mehta SR; Magis-Rodriguez C; Cuevas-Mota J; Moreno-Zuniga PG; Strathdee SA; Harm Reduct J; 2014 Feb; 11():4. PubMed ID: 24520885 [TBL] [Abstract][Full Text] [Related]
8. Opioid agonist treatment and the process of injection drug use initiation. Mittal ML; Jain S; Sun S; DeBeck K; Milloy MJ; Hayashi K; Hadland SE; Werb D Drug Alcohol Depend; 2019 Apr; 197():354-360. PubMed ID: 30922483 [TBL] [Abstract][Full Text] [Related]
10. Gender and the first-time provision of injection initiation assistance among people who inject drugs across two distinct North American contexts: Tijuana, Mexico and Vancouver, Canada. Meyers-Pantele SA; Jain S; Sun X; Marks C; DeBeck K; Hayashi K; Strathdee SA; Werb D Drug Alcohol Rev; 2022 Mar; 41(3):686-696. PubMed ID: 34636100 [TBL] [Abstract][Full Text] [Related]
11. Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US. Des Jarlais DC; Cooper HLF; Arasteh K; Feelemyer J; McKnight C; Ross Z PLoS One; 2018; 13(3):e0194799. PubMed ID: 29596464 [TBL] [Abstract][Full Text] [Related]
12. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California. Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432 [TBL] [Abstract][Full Text] [Related]
13. Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA. Killion JA; Jegede OS; Werb D; Davidson PJ; Smith LR; Gaines T; Graff Zivin J; Zúñiga ML; Pines HA; Garfein RS; Strathdee SA; Rivera Saldana C; Martin NK Int J Drug Policy; 2024 Oct; 132():104557. PubMed ID: 39213827 [TBL] [Abstract][Full Text] [Related]
14. Cross-border migration and initiation of others into drug injecting in Tijuana, Mexico. Rafful C; Melo J; Medina-Mora ME; Rangel G; Sun X; Jain S; Werb D Drug Alcohol Rev; 2018 Apr; 37 Suppl 1(Suppl 1):S277-S284. PubMed ID: 29168262 [TBL] [Abstract][Full Text] [Related]
15. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico. Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Syndemic of Blood-Borne Disease Transmission and Injection Drug Use Initiation at the US-Mexico Border. Rafful C; Jain S; Sun X; Strathdee SA; Garfein RS; Cuevas-Mota J; Magis-Rodríguez C; Smith LR; Werb D J Acquir Immune Defic Syndr; 2018 Dec; 79(5):559-565. PubMed ID: 30222661 [TBL] [Abstract][Full Text] [Related]
17. Self-perception of assisting with future injection drug initiation: The influence of relationships in the process of drug injecting initiation. Bloom BE; Jain S; Sun X; Garfein RS; Strathdee SA; Milloy MJ; Hayashi K; DeBeck K; Bluthenthal R; Werb D; Rafful C Drug Alcohol Rev; 2021 Jan; 40(1):109-117. PubMed ID: 32840027 [TBL] [Abstract][Full Text] [Related]
18. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14). Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R; BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567 [TBL] [Abstract][Full Text] [Related]
19. Involvement of people who inject drugs in injection initiation events: a cross-sectional analysis identifying similarities and differences across three North American settings. Marks C; Meyers SA; Jain S; Sun X; Hayashi K; Gonzalez-Zuniga P; Strathdee SA; Garfein RS; Milloy MJ; DeBeck K; Cummins K; Werb D BMJ Open; 2021 Aug; 11(8):e046957. PubMed ID: 34385244 [TBL] [Abstract][Full Text] [Related]
20. The role of drug treatment and recovery services: an opportunity to address injection initiation assistance in Tijuana, Mexico. Meyers SA; Rafful C; Jain S; Sun X; Skaathun B; Guise A; Gonzalez-Zuñiga P; Strathdee SA; Werb D; Mittal ML Subst Abuse Treat Prev Policy; 2020 Oct; 15(1):78. PubMed ID: 33046125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]